224 related articles for article (PubMed ID: 5527168)
1. On the interaction between neuroleptics and antiparkinson drugs.
Julou L
Mod Probl Pharmacopsychiatry; 1970; 5():50-4. PubMed ID: 5527168
[No Abstract] [Full Text] [Related]
2. Role of brain dopamine in the antipsychotic effect of neuroleptics. Evidence from studies of amphetamine-neuroleptic interaction.
Randrup A
Mod Probl Pharmacopsychiatry; 1970; 5():60-5. PubMed ID: 5527170
[No Abstract] [Full Text] [Related]
3. Neurophysiological substrates of the pharmacological criteria for neuroleptics.
Stille G
Mod Probl Pharmacopsychiatry; 1970; 5():56-60. PubMed ID: 5527169
[No Abstract] [Full Text] [Related]
4. Chemical and pharmacological classification of neuroleptics.
Janssen PA
Mod Probl Pharmacopsychiatry; 1970; 5():33-44. PubMed ID: 5535847
[No Abstract] [Full Text] [Related]
5. Definition and classification of neuroleptics.
Arnold OH; Collard J; Deniker P; Ginestet D; Hippius H; Itil TM; Labhardt F; Leeds AA; Montanini R; Morozov G; Simon P; Villeneuve A
Mod Probl Pharmacopsychiatry; 1970; 5():141-7. PubMed ID: 5527163
[No Abstract] [Full Text] [Related]
6. The neuroleptics. 3. Pharmacology. Introduction.
Van Rossum JM; Janssen PA; Boissier JR; Julou L; Loew DM; Moller Nielsen I; Munkvad I; Randrup A; Stille G; Tedeschi DH
Mod Probl Pharmacopsychiatry; 1970; 5():23-32. PubMed ID: 5527165
[No Abstract] [Full Text] [Related]
7. [Use in psychiatry of antiparkinson drugs].
Bourgeois M; Mazaux JM; Imbert D; Daubech MJ; Daulouède JP; Tignol J
Ann Med Psychol (Paris); 1976 Oct; 2(3):499-510. PubMed ID: 1020859
[No Abstract] [Full Text] [Related]
8. The use of amphetamine induced stereotyped behaviour as a model for the experimental evaluation of antiparkinson agents.
Costall B; Naylor RJ; Wright T
Arzneimittelforschung; 1972 Jul; 22(7):1178-83. PubMed ID: 4404343
[No Abstract] [Full Text] [Related]
9. Pimozide, a chemically novel, highly potent and orally long-acting neuroleptic drug. I. The comparative pharmacology of pimozide, haloperidol, and chlorpromazine.
Janssen PA; Niemegeers CJ; Schellekens KH; Dresse A; Lenaerts FM; Pinchard A; Schaper WK; van Nueten JM; Verbruggen FJ
Arzneimittelforschung; 1968 Mar; 18(3):261-79. PubMed ID: 4386815
[No Abstract] [Full Text] [Related]
10. [The antiparkinson activity of a new adamantane derivative].
Val'dman EA; Voronina TA; Nerobkova LN
Eksp Klin Farmakol; 1999; 62(4):3-6. PubMed ID: 10513325
[TBL] [Abstract][Full Text] [Related]
11. On stereotypy and catalepsy: studies on the effect of amphetamines and neuroleptics in rats.
Fog R
Acta Neurol Scand Suppl; 1972; 50():3-66. PubMed ID: 4565013
[No Abstract] [Full Text] [Related]
12. [Neuroleptics: functional and biochemical effects].
Anden NE
Lakartidningen; 1972 Mar; 69():71-7 passim. PubMed ID: 4664127
[No Abstract] [Full Text] [Related]
13. [Antagonism between anti-Parkinson drugs and neuroleptics. Apropos of various withdrawal experiences, a personal one among them (2nd part)].
Bourgeois M; Bouey P
Ann Med Psychol (Paris); 1976 Nov; 2(4):669-708. PubMed ID: 1020864
[No Abstract] [Full Text] [Related]
14. The effect of anti-Parkinson drugs on catalepsy induced by -methyl-p-tyrosine in rats pretreated with intraventricular 6-hydroxydopamine.
Cashin CH; Sutton S
Br J Pharmacol; 1973 Mar; 47(3):658P-659P. PubMed ID: 4738385
[No Abstract] [Full Text] [Related]
15. Proceedings: CB 154 (2-bromo-alpha-ergokryptine, bromocriptin), a potential anti-Parkinson agent.
Johnson AM; Vigouret JM; Loew DM
Naunyn Schmiedebergs Arch Pharmacol; 1974; 282(Suppl):suppl 282:R40. PubMed ID: 4276573
[No Abstract] [Full Text] [Related]
16. Is it possible to predict the clinical effects of neuroleptic drugs (major tranquillizers) from animal data? IV. An improved experimental design for measuring the inhibitory effects of neuroleptic drugs on amphetamine-or apomorphine-induced "Cheroing" and "agitation" in rats.
Janssen PA; Niemegeers CJ; Schellekens KH; Lenaerts FM
Arzneimittelforschung; 1967 Jul; 17(7):841-54. PubMed ID: 5632842
[No Abstract] [Full Text] [Related]
17. [Extra-pyramidal syndrome caused by neuroleptics].
Lambert PA
Encephale; 1973; 62(1):78-105. PubMed ID: 4718697
[No Abstract] [Full Text] [Related]
18. Antagonism by neuroleptics of abnormal behavior induced by activation of brain dopamine receptors.
Van Rossum JM
Mod Probl Pharmacopsychiatry; 1970; 5():65-7. PubMed ID: 5527171
[No Abstract] [Full Text] [Related]
19. [The antipsychotic action of neuroleptics and basal ganglia function].
Arushanian EB
Farmakol Toksikol; 1973; 26(4):481-9. PubMed ID: 4151298
[No Abstract] [Full Text] [Related]
20. The neuroleptics. 10. Therapeutic problems.
Barahona-Fernandes HJ; Cazzullo CL; Cocchi A; Denber HC; Freyhan FA; Klerman GL; Köknel O; Levine J; Saarma J; Sarteschi P; Vinar O; Wittenborn JR
Mod Probl Pharmacopsychiatry; 1970; 5():148-56. PubMed ID: 4949818
[No Abstract] [Full Text] [Related]
[Next] [New Search]
